USPTO serial 79279654
RIBOMIC
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Dec 8, 2020
- Examiner
- LEE, YATSYE ISADORA
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with RIBOMIC?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $797*
Plus Government fees of $975
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Keith R. Obert
Keith R. Obert Ware, Fressola, Maguire & Barber LLP755 Main Street, Bldg. 5Monroe, CT 06468UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemicals for use in stabilization of RNA before purification and after purification under laboratory experiment and medical examination; chemical reagents for separating, detecting, measuring and analyzing proteins; ribonucleic acid (RNA) for laboratory use; nuclease for scientific or laboratory purposes; unsticking and separating preparations for scientific or laboratory purposes; chemicals for use in industry and science; artificial sweeteners; reagents for medical research | ACTIVE | — |
| 005 | Reagents for medical purposes or medical reagents for diagnostic purposes; chemical preparations for pharmaceutical or medical purposes, namely, for treating vision failure, hearing failure, bone growth failure, lung failure, heart failure, articular failure, mental disorders, central nervous system disorder, blood disorders, skin disorders, pain, inflammation, kidney failure, liver failure, fibrosis, metabolic disorders, endocrine diseases, gynecological diseases, respiratory diseases, cardiovascular diseases, tissue regeneration and cancer; tissue-regenerative pharmaceutical preparations; pharmaceutical preparations for preventing and treating infectious diseases; pharmaceutical preparations and other preparations for destroying vermin, fungicides, herbicides; reagent paper for medical purposes; gauze for dressings; capsules sold empty for pharmaceuticals; adhesive plasters for medical purposes; dental materials, namely, implants comprising living tissues; dietary supplements for humans | ACTIVE | — |
| 042 | Testing, inspecting, analyzing, surveying, and research and development relating to pharmaceuticals; testing, inspecting or researching of medical technologies, and providing information and consultancy services relating thereto; research and development of pharmaceuticals and medical supplies; providing information relating to research of pharmaceuticals and medical supplies; testing, inspecting or researching of chemicals for medical use; quality evaluation and analysis of functions of chemical compositions available for medical purposes; providing information on medical researches; DNA analysis services for scientific research purposes; cytogenetic testing for scientific research purposes; testing, inspection or research of pharmaceuticals, cosmetics or foodstuffs; providing temporary use of on-line non-downloadable computer programs for drug candidate discovery tools on data networks; designing of machines, apparatus, instruments including their parts or systems composed of such machines, apparatus and instruments; testing, inspection or research on agriculture, livestock breeding or fisheries; testing or research in the field of machines, apparatuses and instruments in the field of detection of trace components, hazardous substances and microorganisms | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by RIBOMIC INC.
- Other trademarks owned by RIBOMIC INC.
- Other trademarks owned by RIBOMIC INC.
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 042
- Similar marks named RIBOMIC
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Dec 8, 2025 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Apr 4, 2021 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Mar 11, 2021 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Mar 11, 2021 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Mar 8, 2021 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Dec 8, 2020 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Sep 22, 2020 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Sep 22, 2020 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Sep 18, 2020 | RFNP | REFUSAL PROCESSED BY IB | — |
| Sep 2, 2020 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Aug 20, 2020 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 20, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 20, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 20, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 18, 2020 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 18, 2020 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 18, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 27, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 27, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 27, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 10, 2020 | RFNT | REFUSAL PROCESSED BY IB | — |
| Mar 23, 2020 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Mar 23, 2020 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Mar 6, 2020 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Mar 3, 2020 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Mar 2, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 2, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 2, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Feb 27, 2020 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |